EFFECTS OF ANESTHESIA AND K+ ATP CHANNEL BLOCKADE ON INTERSTITIAL ADENOSINE ACCUMULATION IN ISCHEMIC RABBIT MYOCARDIUM

被引:8
作者
COHEN, MV [1 ]
SNELL, KS [1 ]
TSUCHIDA, A [1 ]
VANWYLEN, DGL [1 ]
DOWNEY, JM [1 ]
机构
[1] ST OLAF COLL,DEPT BIOL,NORTHFIELD,MN 55057
关键词
GLIBENCLAMIDE; KETAMINE-XYLAZINE; PENTOBARBITAL; TOTAL PURINES;
D O I
10.1007/BF00788503
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glibenclamide, a K-ATP(+) channel antagonist, blocks the anti-infarct effect of ischemic preconditioning in rabbits, but only when the latter are anesthetized with ketamine-xylazine. Furthermore, the protection triggered by pinacidil, a K-ATP(+) channel opener, can be aborted by treatment with the adenosine antagonist 8-(P-sulfophenyl)theophylline. This study tests whether either the anesthetic regimen or glibenclamide affects infarct size by modulating interstitial adenosine levels, Interstitial adenosine and total purine concentrations were assessed in open-chest rabbits by the microdialysis technique, Dialysis fibers were inserted into myocardium served by a coronary artery branch surrounded by a snare. All animals sustained a 30-min coronary occlusion and then 120-min reperfusion, Rabbits were anesthetized with either sodium pentobarbital or a ketamine-xylazine mixture, Half of the latter animals also received glibenclamide, The control levels of adenosine in the dialysate were comparable in the three groups, as were: those of total purines, and the infusion of glibenclamide caused no change. Ischemia led to 10- to 20-fold increases in interstitial adenosine and 10- to 40-fold rises in total purine concentrations, These increases were equivalent in all groups, Furthermore, infarct size as a percentage of the myocardium at risk was also comparable in the three groups. Neither the anesthetic agent nor glibenclamide appears to modulate interstitial adenosine release from ischemic tissue.
引用
收藏
页码:410 / 417
页数:8
相关论文
共 34 条
[1]  
AUCHAMPACH JA, 1991, J PHARMACOL EXP THER, V259, P961
[2]   BLOCKADE OF ISCHEMIC PRECONDITIONING IN DOGS BY THE NOVEL ATP DEPENDENT POTASSIUM CHANNEL ANTAGONIST SODIUM 5-HYDROXYDECANOATE [J].
AUCHAMPACH, JA ;
GROVER, GJ ;
GROSS, GJ .
CARDIOVASCULAR RESEARCH, 1992, 26 (11) :1054-1062
[3]   ADENOSINE-A(1) RECEPTORS, K(ATP) CHANNELS, AND ISCHEMIC PRECONDITIONING IN DOGS [J].
AUCHAMPACH, JA ;
GROSS, GJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :H1327-H1336
[4]   THE ALPHA-2-ADRENOCEPTOR ANTAGONIST EFAROXAN MODULATES K+ATP CHANNELS IN INSULIN-SECRETING CELLS [J].
CHAN, SLF ;
DUNNE, MJ ;
STILLINGS, MR ;
MORGAN, NG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (01) :41-48
[5]   ATP-REGULATED K+ CHANNELS PROTECT THE MYOCARDIUM AGAINST ISCHEMIA REPERFUSION DAMAGE [J].
COLE, WC ;
MCPHERSON, CD ;
SONTAG, D .
CIRCULATION RESEARCH, 1991, 69 (03) :571-581
[6]  
DEWEILLE JR, 1989, P NATL ACAD SCI USA, V86, P2971
[7]   AN EXPLANATION FOR THE REPORTED OBSERVATION THAT ATP-DEPENDENT POTASSIUM CHANNEL OPENERS MIMIC PRECONDITIONING [J].
DOWNEY, JM .
CARDIOVASCULAR RESEARCH, 1993, 27 (09) :1565-1565
[8]   BLOCK OF ATP-REGULATED POTASSIUM CHANNELS BY PHENTOLAMINE AND OTHER ALPHA-ADRENOCEPTOR ANTAGONISTS [J].
DUNNE, MJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (04) :1847-1850
[9]   BLOCKADE OF ATP-SENSITIVE POTASSIUM CHANNELS PREVENTS MYOCARDIAL PRECONDITIONING IN DOGS [J].
GROSS, GJ ;
AUCHAMPACH, JA .
CIRCULATION RESEARCH, 1992, 70 (02) :223-233
[10]  
GROVER GJ, 1989, J PHARMACOL EXP THER, V251, P98